Waters Lifts Annual Profit Forecast, Driven by Biosciences Unit Strength
Summary
Waters Corporation has raised its full-year 2026 adjusted profit per share forecast to a range of $14.40-$14.60, up from its previous projection of $14.30-$14.50. The company also increased its full-year organic revenue forecast to $3.37 billion-$3.42 billion. This positive guidance update follows Waters' strong first-quarter results, where it significantly beat analyst estimates with $1.27 billion in revenue and $2.70 adjusted EPS. The robust performance of its biosciences and diagnostics unit, acquired last year from Becton Dickinson (BDX), was highlighted as a key driver for this increased momentum. This raised outlook provides a strong positive signal to the market regarding the company's future profitability and growth trajectory, particularly validating the strategic acquisition. Investors will be watching for continued strong execution and integration of the acquired unit.
At the time of this announcement, WAT was trading at $325.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $29.6B. The 52-week trading range was $275.05 to $414.15. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.